Junshi taps Revitope in discovery stage to develop antibody-based cancer immunotherapies July 14, 2020 By David Ho and Elise Mak No Comments BEIJING – Besides advancing its neutralizing antibodies for COVID-19, Shanghai Junshi Biosciences Co. Ltd. is aiming to expand its pipeline. On July 13, it entered a collaboration with Revitope Oncology Inc.Read More